Behavioral and Clinical Characteristics of Persons Living with Diagnosed HIV Infection—Medical Monitoring Project, United States, 2019 Cycle
- Risk of HIV transmission can be lowered through use of multiple HIV prevention strategies.
- More information on how to protect others.
High-risk sex is defined as not having sustained viral suppression and having condomless sex with an HIV-negative or unknown status partner who was not taking PrEP.
The Medical Monitoring Project (MMP) is a cross-sectional, locally and nationally representative sample survey that assesses the behavioral and clinical characteristics of adults with diagnosed HIV in the United States and Puerto Rico. To learn more about the project, visit Medical Monitoring Project (MMP).
† Median score calculated from a 10-item scale ranging from 0 (no stigma) to 100 (high stigma) that measures four dimensions of HIV stigma: personalized stigma, disclosure concerns, negative self-image, and perceived public attitudes about people living with HIV.
Centers for Disease Control and Prevention. Behavioral and Clinical Characteristics of Persons with Diagnosed HIV Infection—Medical Monitoring Project, United States, 2019 Cycle (June 2019–May 2020). HIV Surveillance Special Report 28. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published August 2021. Accessed [date].
Confidential Information, Referrals, and Educational Material on HIV Infection
CDC-INFO
- 1-800-232-4636 (in English, en Español)
- 1-888-232-6348 (TTY)
- http://wwwn.cdc.gov/dcs/ContactUs/Form
Acknowledgments
This report was prepared by the following staff and contractors of the Division of HIV/AIDS Prevention, CDC: Sharoda Dasgupta, Yunfeng Tie, Linda Beer, Stacy M. Crim, Tim McManus, Mohua Basu, Brittani Carter, Pranesh P. Chowdhury, Jason A. Craw, Hanna B. Demeke, Catherine Espinosa, Rodel Desamu-Thorpe, Jennifer L. Fagan, Mariana Gutierrez, Rikki Johnson, George Khalil, Ruth E. Luna-Gierke, Mabel Padilla, Sandra Stockwell, John Weiser, Kathleen Wu, Michael Friend (desktop publishing), and R. Luke Shouse.
This report is based, in part, on contributions by Medical Monitoring Project (MMP) participants, community and provider advisory boards, interviewers, and abstractors; the Data Coordinating Center for HIV Supplemental Surveillance at ICF International; and members of the Clinical Outcomes Team, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, Georgia.